» Articles » PMID: 6388496

The Structure and Mode of Action of Glycopeptide Antibiotics of the Vancomycin Group

Overview
Publisher Annual Reviews
Specialty Microbiology
Date 1984 Jan 1
PMID 6388496
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

It has been shown that after more than two decades of work on the structure and mode of action of the vancomycin group of antibiotics we have quite a detailed picture of aspects of their binding in vitro. Our introduction has indicated that these antibiotics are of continuing practical importance, whether in clinical use or animal husbandry. It is clear, however, that if one desires to modify these compounds to produce more effective antibiotic agents, more work is required--particularly to understand better the role of the sugar moieties. Nevertheless, with our present knowledge of the structure and mode of action of the antibiotics we can be fairly confident that they represent a group of compounds specifically evolved to aid the survival of the producing organisms by killing or inactivating competing gram-positive bacteria.

Citing Articles

Biguanide-Vancomycin Conjugates are Effective Broad-Spectrum Antibiotics against Actively Growing and Biofilm-Associated Gram-Positive and Gram-Negative ESKAPE Pathogens and Mycobacteria.

Rahn H, Liu X, Chosy M, Sun J, Cegelski L, Wender P J Am Chem Soc. 2024; 146(32):22541-22552.

PMID: 39088791 PMC: 11624893. DOI: 10.1021/jacs.4c06520.


A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens.

Buijs N, Vlaming H, Kotsogianni I, Arts M, Willemse J, Duan Y Proc Natl Acad Sci U S A. 2024; 121(29):e2315310121.

PMID: 38990944 PMC: 11260088. DOI: 10.1073/pnas.2315310121.


Potent and specific antibiotic combination therapy against Clostridioides difficile.

Chioti V, McWhorter K, Blue T, Li Y, Xu F, Jeffrey P Nat Chem Biol. 2024; 20(7):924-933.

PMID: 38942968 PMC: 11306116. DOI: 10.1038/s41589-024-01651-z.


Diazirine Photoprobes for the Identification of Vancomycin-Binding Proteins.

Rotsides P, Lee P, Webber N, Grasty K, Beld J, Loll P ACS Bio Med Chem Au. 2024; 4(2):86-94.

PMID: 38645928 PMC: 11027123. DOI: 10.1021/acsbiomedchemau.3c00067.


Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy.

Hourigan D, Stefanovic E, Hill C, Ross R BMC Microbiol. 2024; 24(1):103.

PMID: 38539119 PMC: 10976773. DOI: 10.1186/s12866-024-03243-2.